NCT01239745 - Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Breast Neoplasms

Interventions

DRUG

Aromasin

Aromasin® one 25 mg tablet to be taken once daily

Trial Locations (11)

Clinic for Tumors, Zagreb

"University Hospital Center Sestre milosrdnice", Zagreb

Institute for Oncology and Radiology of Serbia, Belgrade

Oncology Clinic, Medical center, Bezanijska Kosa, Belgrade

North Estonia Medical Centre Foundation, Tallinn

University Hospital Center Split, Split

University Hospital Center Osijek, Osijek

General Hospital Varazdin, Varaždin

General Hospital Karlovac, Karlovac

University Hospital Center Rijeka, Rijeka

General Hospital Pula, Pula